Shadi Aghamohammad

Dr. Shadi Aghamohammad


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2024 in Medicine
Verified
Journal Article
Open access
ASAmin Sepehr
Amin Sepehr
SMSeyedeh Tina Miri
Seyedeh Tina Miri
SAShadi Aghamohammad
Shadi Aghamohammad
NRNazanin Ma Rahimirad
Nazanin Ma Rahimirad
MMMahnaz Milani
Mahnaz Milani
MRMahdi Rohani
Mahdi Rohani
Gut microbiota and its metabolic activities can influence the physiology and pathology of the human body. It is well established that alterations in the balance of living microbiota can contribute to various health problems, such as inflammatory bowel disease and autoimmune disorders. Probiotics administered in sufficient quantities as functional food ingredients provide health benefits to hosts. They help to maintain the stability and composition of the gut microbiota and provide resistance to infection by pathogens. The most important probiotic bacteria are Lactobacillus spp. and Bifidobacteria spp., which protect the intestine through various mechanisms such as the production of organic acids and bacteriocins. Scientific and clinical research has demonstrated that probiotics play a role in modulating immune response and preventing cancer and chronic inflammatory diseases, especially in the gastrointestinal tract. This article summarizes the potential health benefits, antimicrobial activities, and purposes for which probiotics can be used as functional foods to improve human health.

8 November 2022 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
SAShadi Aghamohammad
Shadi Aghamohammad
ASAmin Sepehr
Amin Sepehr
SMSeyedeh Tina Miri
Seyedeh Tina Miri
MRMahdi Rohani
Mahdi Rohani
MPMohammad R. Pourshafie
Mohammad R. Pourshafie
MRMahdi Rohani
Mahdi Rohani
Objective. IBD is an inflammatory disease with abnormalities such as dysbiosis and abnormal immune system activity. Probiotics, as live beneficial microorganisms, play a role in maintaining health through various mechanisms, including the modulation of the immune system and the control of inflammation. Here, we aimed to investigate the efficacy of a probiotic mixture of Lactobacillus spp. and Bifidobacterium spp. in modulating JAK/STAT and NF-kB inflammatory signaling pathways. Method. A quantitative real-time polymerase chain reaction (qPCR) assay was conducted to analyze the expression of JAK/STAT and inflammatory genes after treatment with the probiotic mixture before, after, and simultaneously with the sonicated pathogen in the HT-29 cell line. The production of IL-6 and IL-1β after probiotic treatment was investigated via cytokine assay. Results. Treatment with probiotics resulted in downregulation of TIRAP, IRAK4, NEMO, and RIP genes in the NF-kB pathway and JAK/STAT genes compared with sonicat-treated cells as inflammation inducers. The production of IL-6 and IL-1 decreased after probiotic treatment. Conclusions. The probiotic mixture of Lactobacillus spp. and Bifidobacterium spp. showed anti-inflammatory effects by modulating JAK/STAT and NF-kB signaling pathways. The use of probiotics could be considered as an appropriate complementary treatment for patients with inflammatory bowel disease.

11 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FJFatemeh Haririzadeh Jouriani
Fatemeh Haririzadeh Jouriani
MTMahdi Torkamaneh
Mahdi Torkamaneh
MTMahnaz Torfeh
Mahnaz Torfeh
FAFatemeh Ashrafian
Fatemeh Ashrafian
SAShadi Aghamohammad
Shadi Aghamohammad
MRMahdi Rohani
Mahdi Rohani
Probiotics are beneficial microorganisms that modulate various signaling pathways to improve human health status. In this study we aimed to evaluate the precise molecular effects of Lactobacillus spp., Bifidobacterium spp., and a mixture of our native potential probiotics on the autophagy signaling pathway during the presence of inflammation. The evaluation of autophagy gene expression was performed after exposing the HT -29 cell line with the sonicated pathogens and probiotics, before and simultaneously with inflammation induction by quantitative real-time polymerase chain reaction (qPCR) and cytokine assays. The results of the current study showed that our native potential probiotic cocktails could upregulate the expression level of the autophagy genes including pik3c3, atg14, beclin, pik3r4, atg5, atg16, atg7, and atg3 compared with sonicated pathogen treatments, and also these native potential probiotic strains could exert anti-inflammatory effects, especially before inflammation induction. In conclusion, our native potential probiotic cocktail indicated the preventive and therapeutic effect on inflammation, but our selected probiotics could affect autophagy genes stronger before inflammation compared to expose simultaneously with inflammation. Therefore, the administration of probiotics as a prophylactic agent with the least side effects could be considered a suitable treatment for patients with inflammatory-related disease, even before or at the beginning of inflammation.

28 August 2023 in Heliyon
Verified
Journal Article
Open access
SAShadi Aghamohammad
Shadi Aghamohammad
ASAmin Sepehr
Amin Sepehr
SMSeyedeh Tina Miri
Seyedeh Tina Miri
MRMahdi Rohani
Mahdi Rohani
MPMohammad R. Pourshafie
Mohammad R. Pourshafie
MRMahdi Rohani
Mahdi Rohani
IBD is considered a relapsing disease with relapsing phases. Probiotics are beneficial microorganisms that modulate inflammatory signaling pathways. Our aim was to identify the precise molecular effects of probiotics on inflammatory signaling pathways during the presence of inflammation. Evaluation of the expression of JAK/STAT and inflammatory genes after treatment of the HT -29 cell line with the sonicated pathogens and probiotics, simultaneously was performed by quantitative real-time polymerase chain reaction (qPCR) assay. The production of IL-6 and IL-1β after administration of probiotics was conducted by means of cytokine assay. The probiotic cocktail resulted in the downregulation of TIRAP, IRAK4, NEMO, and RIP genes in the NF-кB pathway compared with Sonicat-treated cells. The expression of JAK/STAT genes was various after probiotic treatment. The application of probiotics has been observed to result in a notable decrease in the production of IL-6 and IL-1β. The investigated probiotic cocktail, especially Bifidobacterium spp. showed anti-inflammatory effects on HT -29 cells via modulation of JAK/STAT and NF-кB signaling pathways. The use of probiotics with the least side effects could be considered a suitable treatment for patients with inflammatory bowel disease, even at the beginning of inflammation.

20 July 2013 in Archives of Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
HGHossein Goudarzi
Hossein Goudarzi
SAShadi Aghamohammad
Shadi Aghamohammad
AHAli Hashemi
Ali Hashemi
BNBahram Nikmanesh
Bahram Nikmanesh
MNMaryam Noori
Maryam Noori
Background: Emerging antibacterial resistance rates and extended-spectrum-β-lactamase producing Escherichia coli recovered from urinary tract infections (UTI) is an increasing problem in different regions, limiting therapeutic options. Objectives: The aim of this study was the detection of blaTEM, blaSHV and blaCTX-M genes among Escherichia coli strains causing Urinary Tract Infection in children from Iran. Materials and Methods: A total of 100 Escherichia coli isolates were collected from urine specimens of patients with UTI who had referred to the Children Medical Center, Tehran, Iran between November 2012 and July 2013. Antibiotic susceptibility test was performed by Kirby-Bauer disc diffusion method according to CLSI guidelines. The blaCTX-M, blaTEM and blaSHV genes were detected by PCR and sequencing methods. Results: The resistance rate of isolates to cefotaxime, ceftazidime, imipenem, gentamicin, amikacin, cefepime, piperacillin/tazobactam, co-trimoxazole, nitrofurantoin, cefixime and cephalothin, were 51 (51%), 24 (24%), 0 (0%), 25 (25%), 2 (2%), 6 (6%), 2 (2%), 79 (79%), 7 (7%), 36 (36%) and 43 (43%), respectively. In this study, imipenem was more active than other antibiotics. The existence of blaTEM-1 and blaCTX-M-15 was detected in 69 (69%) and 74 (74%) isolates respectively, while blaSHV gene was not detected. Conclusions: The prevalence of β-lactamase-producing genes in E. coli detected by this study is of great concern and highlights the need of infection control measures including antibacterial management and prompt identification of isolates with beta-lactamase-producing genes. Keywords: Escherichia coli; Urinary Tract Infections; Child; beta-Lactamases

FJFatemeh Haririzadeh Jouriani
Fatemeh Haririzadeh Jouriani
NRNiloofar Rezaie
Niloofar Rezaie
FAFatemeh Ashrafian
Fatemeh Ashrafian
SAShadi Aghamohammad
Shadi Aghamohammad
MRMahdi Rohani
Mahdi Rohani